Related news from
Thu, 25 Apr 2024 14:02:01 +0000	Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu, 25 Apr 2024 13:15:26 +0000	Seeking Clues to Stryker (SYK) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics Evaluate the expected performance of Stryker (SYK) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Wed, 24 Apr 2024 16:44:00 +0000	SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings? SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.
Wed, 24 Apr 2024 12:23:58 +0000	What Makes Stryker Corporation (SYK) an Investment Choice? Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
Wed, 24 Apr 2024 11:00:10 +0000	Does Stryker (NYSE:SYK) Deserve A Spot On Your Watchlist? Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Wed, 24 Apr 2024 10:25:00 +0000	Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Tue, 23 Apr 2024 14:00:58 +0000	Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sun, 21 Apr 2024 12:30:17 +0000	This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.
Thu, 18 Apr 2024 13:35:55 +0000	3 Robotics Stocks to Turn $1000 into $1 Million: April 2024 Robotics and related technologies, such as workflow automation products, cloud services, and generative AI technology, have captivated the investing community. They have assisted in leading the overall market higher over this past year especially. Investors are very interested in technology companies focused on innovation and the rollout of brand-new products and services. With the technology sector booming, it’s a perfect time for investors to jump into these robotics companies with a great fut
Wed, 17 Apr 2024 15:07:00 +0000	Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay Henry Schein (HSIC) is busy promoting digital workflows for general dentistry and dental specialties.
Wed, 17 Apr 2024 14:26:00 +0000	Here's Why You Should Retain Chemed (CHE) Stock for Now Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
Tue, 16 Apr 2024 15:50:00 +0000	Here's Why You Should Retain Charles River (CRL) Stock Now Investors are optimistic about Charles River (CRL) owing to strength in RMS and DSA segments.
Tue, 16 Apr 2024 14:56:00 +0000	Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition Bio-Rad's (BIO) margin performance bears the brunt of elevated raw material costs, increased logistics costs and higher employee-related expenses.
Tue, 16 Apr 2024 14:00:20 +0000	Institutional investors in Stryker Corporation (NYSE:SYK) lost 3.0% last week but have reaped the benefits of longer-term growth Key Insights Institutions' substantial holdings in Stryker implies that they have significant influence over the...
Fri, 12 Apr 2024 14:45:00 +0000	Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.
Thu, 11 Apr 2024 13:15:00 +0000	Smith+Nephew (SNN) Expands in Australia With New Alliance The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.
Wed, 10 Apr 2024 15:10:00 +0000	Align Technology (ALGN) Up 20.5% YTD: Will the Rally Continue? Investors are optimistic about Align Technology (ALGN) driven by geographic expansion and upbeat guidance.
Wed, 10 Apr 2024 13:30:00 +0000	Boston Scientific (BSX) Faces Rising Costs, Competition With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.
Tue, 09 Apr 2024 13:10:00 +0000	Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.
Tue, 09 Apr 2024 13:03:00 +0000	Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes Labcorp (LH) is investing in innovation and technology that supports diagnostic and drug development testing for various diseases such as cancer and Alzheimer's.